Brooks Laboratories (NSE:BROOKS) Total Liabilities : ₹0.0 Mil (As of Dec. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Brooks Laboratories Total Liabilities?

Brooks Laboratories's Total Liabilities for the quarter that ended in Dec. 2024 was ₹0.0 Mil.

Brooks Laboratories's quarterly Total Liabilities increased from Jun. 2024 (₹0.00 Mil) to Sep. 2024 (₹319.16 Mil) but then declined from Sep. 2024 (₹319.16 Mil) to Dec. 2024 (₹0.00 Mil).

Brooks Laboratories's annual Total Liabilities declined from Mar. 2022 (₹615.92 Mil) to Mar. 2023 (₹356.44 Mil) and declined from Mar. 2023 (₹356.44 Mil) to Mar. 2024 (₹248.60 Mil).

Brooks Laboratories Total Liabilities Historical Data

The historical data trend for Brooks Laboratories's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brooks Laboratories Total Liabilities Chart

Brooks Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

594.48

829.29

615.92

356.44

248.60

Brooks Laboratories Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															-	248.60	-	319.16	-

Brooks Laboratories Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Brooks Laboratories's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	230.476	+	(3.565	+	5.306
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	9.254	+	0)
	=	248.6

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	904.454	-	655.853
	=	248.6

Brooks Laboratories's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	N/A

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	N/A	-	N/A
	=	N/A

Brooks Laboratories Total Liabilities Related Terms

Thank you for viewing the detailed overview of Brooks Laboratories's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Brooks Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brooks Laboratories Ltd (NSE:BROOKS) » Definitions » Total Liabilities

Traded in Other Exchanges

533543:India

Address

Off. Andheri Kurla Road, 201, The Summit Business Park, Behind Guru Nanak Petrol Pump, Andheri (East), Mumbai, MH, IND, 400 093

Website

https://www.brookslabs.net

Brooks Laboratories Ltd is an Indian company operating in the healthcare sector. The company is engaged in the formulation, development, production, and export of drugs and pharmaceuticals. The company operates under one segment: Pharmaceutical products including ingredients and intermediaries. It manufactures drugs in a variety of forms, including tablets, dry syrup, injections, liquid injections, dry powder injections, eye drops, and ear drops. Its products include carbapenem and penicillins.

Brooks Laboratories Headlines

No Headlines